Comment: Caspofungin Acetate for Treatment of Invasive Fungal Infections

Pacetti SA Gelone S P. Caspofungin acetate for treatment of invasive fungal infections. Ann Pharmacother 2003;37:90–8. DOI 10.1345/aph.1C114.

Chan J. Comment: Caspofungin acetate for treatment of invasive fungal infections (letter). Ann Pharmacother 2003;37:595.

Mosquera J Sharp A Moore CB Warn PA Denning DW. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp. J Antimicrob Chemother 2002;50: 189–94.

Saag MS Graybill RJ Larsen RA Pappas PG Perfect JR Powderly WG Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000;30:710–8.

Rex JH Walsh TJ Sobel JD Filler SG Pappas PG Dismukes WE Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000;30:662–78.

Rubin MA Carroll KC Cahill BC. Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans. Clin Infect Dis 2002;34:1160–1.

Nivoix Y Zamfir A Lutum P Kara F Remy V Lioure B Caspo-fungine plus amphotericine B ou azole dans le traitement de deuxiéme ligne d'infections fongiques invasives. Revue de 11 cases (abstract). Presented at: Congrès de la Societé Française de Mycologie Médicale. Insti-tut Pasteur, Paris, November 29–30, 2002.

Aliff TB Maslak PG Jurcic JG Heaney ML Cathcart KN Sepkowitz KA Refractory Aspergillus pneumonia in patients with acute leukemia. Cancer 2003;97:1025–32.